Showing results (11-20 of 299) with videos related to
Sort By:
Pageof 30
AJNR. American Journal of Neuroradiology|July 16, 2011
The globe and orbit in Laron syndromeL Kornreich, O Konen, P Lilos, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|November 26, 1998
Serum leptin in obese patients with Laron syndrome before and during IGF-I treatmentZ Laron, A Silbergeld, P Lilos, et al.Metabolism: Clinical and Experimental|October 1, 1995
Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatmentZ Laron, Y Avitzur, B KlingerJournal of Pediatric Endocrinology & Metabolism : JPEM|July 7, 1999
Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome)Z Laron, B Klinger, A SilbergeldJournal of Pediatric Endocrinology & Metabolism : JPEM|June 5, 2009
Hand size and growth in untreated and IGF-I treated patients with Laron syndromeO Konen, A Silbergeld, P Lilos, et al.Clinical Endocrinology|December 1, 1993
Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short childrenR Eshet, B Klinger, A Silbergeld, et al.Acta Endocrinologica|October 1, 1989
Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfismZ Laron, B Klinger, B Erster, et al.Lancet (London, England)|November 19, 1988
Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfismZ Laron, B Klinger, B Erster, et al.Regulatory Peptides|October 20, 1993
Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS)R Eshet, B Klinger, A Silbergeld, et al.Developmental Pharmacology and Therapeutics|January 1, 1990
Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfsB Klinger, M Garty, A Silbergeld, et al.Pageof 30